Background Genomic research is challenging the tradition of informed consent. Genomic researchers in the USA, Canada and parts of Europe are encouraged to use informed consent to address the prospect of disclosing individual research results (IRRs) to study participants. In the USA, no national policy exists to direct this use of informed consent, and it is unclear how local institutional review boards (IRBs) may want researchers to respond.
Objective and methods To explore publicly accessible IRB websites for guidance in this area, using summative content analysis.
Findings Three types of research results were addressed in 45 informed consent templates and instructions from 20 IRBs based at centres conducting genomic research: (1) IRRs in general, (2) incidental findings (IFs) and (3) a broad and unspecified category of ‘significant new findings’ (SNFs). IRRs were more frequently referenced than IFs or SNFs. Most documents stated that access to IRRs would not be an option for research participants. These non-disclosure statements were found to coexist in some documents with statements that SNFs would be disclosed to participants if related to their willingness to participate in research. The median readability of template language on IRRs, IFs and SNFs exceeded a ninth-grade level.
Conclusion IRB guidance may downplay the possibility of IFs and contain conflicting messages on IRR non-disclosure and SNF disclosure. IRBs may need to clarify why separate IRR and SNF language should appear in the same consent document. The extent of these issues, nationally and internationally, needs to be determined.
- Genomic research results
- informed consent
- institutional review boards
- ethics committees/consultation
- research ethics
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Guideline for feedback of individual genetic research findings for genomics research in Africa
- Ethics of ‘Counting Me In’: framing the implications of direct-to-patient genomics research
- Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents
- Webinar report: stakeholder perspectives on informed consent for the use of genomic data by commercial entities
- Navigating the ethical maze of genomics in Canada’s military
- ‘Ethical responsibility’ or ‘a whole can of worms’: differences in opinion on incidental finding review and disclosure in neuroimaging research from focus group discussions with participants, parents, IRB members, investigators, physicians and community members
- How anonymous is ‘anonymous’? Some suggestions towards a coherent universal coding system for genetic samples
- Taking it to the bank: the ethical management of individual findings arising in secondary research
- Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues
- Defining and managing incidental findings in genetic and genomic practice